September 22, 2017 3:15 AM ET


Company Overview of Laboratorios Andromaco S.A.

Key Executives for Laboratorios Andromaco S.A.

NameBoard RelationshipsTitleAge
Andres Rudolphy Fontaine 6 RelationshipsVice-President of the Board of Directors and Chief Executive Officer--
Sergio Weinstein Aranda 6 RelationshipsChairman and President--
Eric-Paul Pâques Ph.D.14 RelationshipsPresident and Director63
Oscar Ferenczi No RelationshipsGeneral Manager--

Laboratorios Andromaco S.A. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sergio Weinstein Aranda 6 RelationshipsLaboratorios Andromaco S.A.--
Andres Rudolphy Fontaine 6 RelationshipsLaboratorios Andromaco S.A.--
Eric-Paul Pâques Ph.D. 14 RelationshipsLaboratorios Andromaco S.A.63
Robin Schäde 6 RelationshipsLaboratorios Andromaco S.A.--
Stefan Genten 14 RelationshipsAltana AG49
View All Board Members

Laboratorios Andromaco S.A. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Laboratorios Andromaco S.A. CEO Compensation
Industry Average


Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals A/S
September 20, 2017 9:03 PM ET
Sucampo Pharmaceuticals, Inc. Announces Appointment of Alex Driggs to General Counsel and Corporate Secretary
September 20, 2017 8:15 PM ET
DURECT Corporation Appoints Myriam Theeuwes as Senior Vice President, Clinical Development
September 20, 2017 12:00 PM ET
Kilitch Drugs (India) Limited Announces Executive Changes
September 20, 2017 11:47 AM ET
Mallinckrodt Pharmaceuticals Announces the Election of David Norton to the Company's Board of Directors
September 20, 2017 10:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Laboratorios Andromaco S.A., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at